Cite
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.
MLA
Rijckborst, Vincent, et al. “Long-Term Follow-up of Hepatitis B e Antigen-Negative Patients Treated with Peginterferon α-2a: Progressive Decrease in Hepatitis B Surface Antigen in Responders.” European Journal of Gastroenterology & Hepatology, vol. 24, no. 9, Sept. 2012, pp. 1012–19. EBSCOhost, https://doi.org/10.1097/MEG.0b013e3283557e23.
APA
Rijckborst, V., Ferenci, P., Akdogan, M., Pinarbasi, B., ter Borg, M. J., Simon, K., Flisiak, R., Akarca, U. S., Raptopoulou-Gigi, M., Verhey, E., van Vuuren, A. J., Boucher, C. A., Hansen, B. E., & Janssen, H. L. A. (2012). Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders. European Journal of Gastroenterology & Hepatology, 24(9), 1012–1019. https://doi.org/10.1097/MEG.0b013e3283557e23
Chicago
Rijckborst, Vincent, Peter Ferenci, Meral Akdogan, Binnur Pinarbasi, Martijn J ter Borg, Krzysztof Simon, Robert Flisiak, et al. 2012. “Long-Term Follow-up of Hepatitis B e Antigen-Negative Patients Treated with Peginterferon α-2a: Progressive Decrease in Hepatitis B Surface Antigen in Responders.” European Journal of Gastroenterology & Hepatology 24 (9): 1012–19. doi:10.1097/MEG.0b013e3283557e23.